In light of the present knowledge on the neurobiological and behavioral consequences of elevated IL-6 concentrations, these data strongly suggest that brain inflammation is likely involved in the pathogenesis of the neuropsychiatric symptoms associated with MetS. This evidence concerns the gene IL6 and metabolic syndrome.